Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum

randomized controlled trial

  • A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
    You have accessRestricted Access
    A Randomized Clinical Trial of Anti–IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
    Konstantin Doberer, Michael Duerr, Philip F. Halloran, Farsad Eskandary, Klemens Budde, Heinz Regele, Jeff Reeve, Anita Borski, Nicolas Kozakowski, Roman Reindl-Schwaighofer, Johannes Waiser, Nils Lachmann, Sabine Schranz, Christa Firbas, Jakob Mühlbacher, Georg Gelbenegger, Thomas Perkmann, Markus Wahrmann, Alexander Kainz, Robin Ristl, Fabian Halleck, Gregor Bond, Edward Chong, Bernd Jilma and Georg A. Böhmig
    JASN December 2020, ASN.2020071106; DOI: https://doi.org/10.1681/ASN.2020071106
    Add to Selected Citations
  • You have accessRestricted Access
    Role of Roxadustat for ESA-Resistant Renal Anemia? —Read with Caution
    Mototsugu Tanaka, Kayo Shinohara, Akiko Ono and Mutsuhiro Ikuma
    JASN November 2020, 31 (11) 2737; DOI: https://doi.org/10.1681/ASN.2020060821
    Add to Selected Citations
  • Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
    You have accessRestricted Access
    Intravenous Iron Dosing and Infection Risk in Patients on Hemodialysis: A Prespecified Secondary Analysis of the PIVOTAL Trial
    Iain C. Macdougall, Sunil Bhandari, Claire White, Stefan D. Anker, Kenneth Farrington, Philip A. Kalra, Patrick B. Mark, John J. V. McMurray, Chante Reid, Michele Robertson, Charles R.V. Tomson, David C. Wheeler, Christopher G. Winearls, Ian Ford and on behalf of the PIVOTAL Investigators and Committees
    JASN May 2020, 31 (5) 1118-1127; DOI: https://doi.org/10.1681/ASN.2019090972
    Add to Selected Citations
  • You have accessRestricted Access
    A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD
    Yusuke Sakaguchi, Takayuki Hamano, Yoshitsugu Obi, Chikako Monden, Tatsufumi Oka, Satoshi Yamaguchi, Isao Matsui, Nobuhiro Hashimoto, Ayumi Matsumoto, Karin Shimada, Yoshitsugu Takabatake, Atsushi Takahashi, Jun-Ya Kaimori, Toshiki Moriyama, Ryohei Yamamoto, Masaru Horio, Koichi Yamamoto, Ken Sugimoto, Hiromi Rakugi and Yoshitaka Isaka
    JASN June 2019, 30 (6) 1073-1085; DOI: https://doi.org/10.1681/ASN.2018111150
    Add to Selected Citations
  • A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
    You have accessRestricted Access
    A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
    Farsad Eskandary, Heinz Regele, Lukas Baumann, Gregor Bond, Nicolas Kozakowski, Markus Wahrmann, Luis G. Hidalgo, Helmuth Haslacher, Christopher C. Kaltenecker, Marie-Bernadette Aretin, Rainer Oberbauer, Martin Posch, Anton Staudenherz, Ammon Handisurya, Jeff Reeve, Philip F. Halloran and Georg A. Böhmig
    JASN February 2018, 29 (2) 591-605; DOI: https://doi.org/10.1681/ASN.2017070818
    Add to Selected Citations
  • You have accessRestricted Access
    Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
    Karine Dahan, Hanna Debiec, Emmanuelle Plaisier, Marine Cachanado, Alexandra Rousseau, Laura Wakselman, Pierre-Antoine Michel, Fabrice Mihout, Bertrand Dussol, Marie Matignon, Christiane Mousson, Tabassome Simon and Pierre Ronco
    JASN January 2017, 28 (1) 348-358; DOI: https://doi.org/10.1681/ASN.2016040449
    Add to Selected Citations

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire